| Please join Morgan Lewis corporate partner and shareholder activism defense practice leader Keith E. Gottfried and Morgan Lewis corporate partner Sean M. Donahue for the webinar, "Shareholder Activism Defense: Why Companies Should Consider a Poison Pill in the Wake of COVID-19." |
| In recent weeks, many companies have seen their market capitalizations substantially reduced in the wake of unprecedented volatility in the financial markets driven by the heightened uncertainty surrounding the ongoing coronavirus (COVID-19) pandemic and its impact on the global macroeconomic landscape. Many companies may now be perceived as extremely attractive targets, even “sitting ducks,” for activist investors, corporate raiders, and/or hostile acquirers. During this 60-minute webinar, we will discuss why companies should consider adopting a poison pill (more technically known as a shareholder rights plan), whether a traditional takeover defense poison pill or an NOL poison pill intended to preserve potentially valuable tax assets, or should be prepared with a “shelf” poison pill that can be adopted on very short notice. | |
| About the Morgan Lewis Shareholder Activism Defense Practice | |
| Morgan Lewis’s nationally recognized shareholder activism defense practice advises public companies in a wide array of industries with respect to preparing for and/or responding to high-profile proxy contests, special meeting demands, consent solicitations, withhold and vote-no campaigns, shareholder proposals, and other activist shareholder campaigns as well as contests for corporate control and contested M&A situations. Our shareholder activism defense practice also advises on strategies for lessening a company’s vulnerability to activist shareholders, strategic communications, shareholder engagement, board composition enhancement, and board advisory and corporate governance matters. Read more about our shareholder activism defense practice. | |
 | |
| WHEN | |
| Wednesday, April 1, 2020 12:00 pm ET | |
| Presenters | |
 | |
| Keith E. Gottfried | |
| Corporate partner and shareholder activism defense practice leader, Morgan Lewis | |
 | |
| Sean M. Donahue | |
| Corporate partner, shareholder activism defense practice, Morgan Lewis | |
| CREDIT | |
| CLE credit in CA, IL, NY, PA, TX, and VA is currently pending approval. CLE credit in CT, FL, and NJ is pending approval via reciprocity. | |
|
